BMO Capital Initiates Coverage On On Holding with Market Perform Rating, Announces Price Target of $28
BMO Capital analyst Kelly Crago initiates coverage on On Holding (NYSE:ONON) with a Market Perform rating and announces Price Target of $28.
News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
30 headlines
BMO Capital analyst Kelly Crago initiates coverage on On Holding (NYSE:ONON) with a Market Perform rating and announces Price Target of $28.
BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $60 to $56.
Alphabet Finland AI spending expands with a 13 billion euro plan as GOOG slips and investors watch technical pressure.
Together, Alliant and Blend have created an end-to-end digital home lending experience designed to simplify one of the biggest financial decisions people make. Members will be able to move from instant mortgage
Apple gains chipset market share in Q2 via strong iPhone 17 demand, while Qualcomm & MediaTek face pressure from memory shortages.
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and maintains $16 price target.
Eltek Ltd. (NASDAQ:ELTK), a leading global manufacturer of high-quality printed circuit boards, today announced that Mr. Eli Yaffe, Chief Executive Officer of the Company, has informed the Board of Directors (the
The 2026 PEA was prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects ("NI 43-101") by independent Qualified Persons from Lycopodium (Americas) Ltd
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $10 price target.
Replacing the incumbent vendor, VNPT gains AI-driven anomaly detection to safeguard roaming service qualityTEL AVIV, Israel, Sept. 9, 2026 /PRNewswire/ -- RADCOM Ltd. (NASDAQ:RDCM) announced today that VNPT (Vietnam
The CISO Command Center reinforces Wipro’s consulting-led cybersecurity strategy by enablingenterprises to move from tool-driven operations to an enterprise-wide, risk-led operating model.The Center will be
BKV Corporation ("BKV" or the "Company") (NYSE:BKV) announced today that it intends to offer, subject to market conditions, $400 million aggregate principal amount of convertible senior notes due 2031
Canterra Minerals announced significant drill results from its Buchans Project in Newfoundland, including a 144-meter intercept of 0.75% CuEq at the Lundberg Deposit with a higher-grade 76-meter core of 1.00% CuEq. The company is advancing toward a mineral resource estimate for Lundberg in Q4 2026 and continuing Phase 2 drilling across multiple satellite deposits, with 6,000 meters allocated for broader district exploration.
Capricor Therapeutics faces a securities fraud class action lawsuit alleging the company made false statements about its lead product Deramiocel and misrepresented clinical data integrity in its FDA Biologics License Application. The lawsuit was triggered by a 64.5% stock drop on July 27, 2026, following FDA briefing documents that raised concerns about post-hoc changes to the statistical analysis plan. Investors have until September 28, 2026 to request lead plaintiff status.
ODDITY Tech (NASDAQ:ODD) sees FY2026 sales of $655.974 million vs $628.063 million analyst estimate.
Filed: 2026-09-09 AccNo: 0001193125-26-385888 Size: 956 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
MICVO demonstrated rapid and deep responses, with a 36% confirmed objective response rate (cORR) and 94% disease control rate (DCR), with clinical activity observed across HPV status and prior-treatment
Filed: 2026-09-09 AccNo: 0000928054-26-000087 Size: 5 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
BMO Capital analyst Kelly Crago initiates coverage on Birkenstock Holding (NYSE:BIRK) with a Market Perform rating and announces Price Target of $35.
RAD301 is a peptide-based molecule bound to Gallium-68 (Ga-68) that targets αvβ6-integrin, a cellular marker for tumor invasion and metastatic growth, the expression of which correlates with decreased survival in
DKET Systems operate across Ku, Ka and X-band networks. The award represents a significant expansion of Gilat DataPath's long-standing DKET activity and further strengthens Gilat Defense's position in larger and
TTAN: -20% | ServiceTitan shares are trading lower after the company reported Q2 financial results and issued Q3 sales guidance with its midpoint below estimates. CASY: -10% | Casey's General Stores Q1 EPS $7.37
Filed: 2026-09-09 AccNo: 0001628280-26-061015 Size: 639 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits